# Association of Dual Eligibility and Medicare Type With Quality of Postacute Care After Stroke

**Authors:** Amol M. Karmarkar, Lin-Na Chou, Tarang Jain, Robert Burke, Maricruz Rivera-Hernandez, Corey R. Fehnel, Margaret French, Amit Kumar

PMC · DOI: 10.1001/jamanetworkopen.2026.0095 · JAMA Network Open · 2026-02-24

## TL;DR

Dual-eligible and Medicare Advantage beneficiaries with stroke are less likely to be discharged to high-quality postacute care facilities compared to non-dual-eligible Medicare fee-for-service beneficiaries.

## Contribution

The study identifies disparities in postacute care quality for dual-eligible and Medicare Advantage stroke patients, suggesting targeted interventions could reduce these gaps.

## Key findings

- Dual-eligible and Medicare Advantage beneficiaries had lower odds of being discharged to high-quality skilled nursing facilities.
- Non–dual-eligible Medicare Advantage beneficiaries were less likely to receive care from high-quality home health agencies.
- No significant differences were found in the quality of inpatient rehabilitation facilities used across groups.

## Abstract

Are there differences by Medicare type and dual eligibility status associated with discharge to quality postacute care settings for patients with stroke?

In this cohort study of 44 078 older patients hospitalized for stroke, dual-eligible beneficiaries in Medicare fee-for-service (FFS) plans, non–dual-eligible beneficiaries in Medicare Advantage (MA) plans, and dual-eligible beneficiaries in MA plans had a lower likelihood of discharge to high-quality nursing homes compared with non–dual-eligible beneficiaries in FFS Medicare plans.

This study suggests that dual-eligible and MA beneficiaries with stroke experience disparities in receiving high-quality postacute care; improving awareness of postacute care facility quality ratings among patients, caregivers, and discharge planners, along with having high-quality facilities in the MA plan network, can help reduce these disparities.

The growth of Medicare Advantage (MA) enrollment has reshaped postacute care utilization, particularly among dual-eligible beneficiaries who experience a disproportionate burden of stroke. Recent evidence shows that MA plans are proactive in managing care and directing enrollees toward narrower networks of postacute facilities for greater efficiency.

To compare the likelihood of discharge to high-quality inpatient rehabilitation facilities (IRFs), skilled nursing facilities (SNFs), and home health (HH) care after stroke-related acute hospitalization among dual-eligible Medicare-Medicaid beneficiaries enrolled in MA vs Medicare fee-for-service (FFS) plans.

This retrospective cohort study used a 20% random sample of Medicare data and included Medicare beneficiaries aged 65 years or older hospitalized for ischemic stroke between January 1, 2021, and September 3, 2022, with follow-up of postacute care use. The data were analyzed between February 1 and December 28, 2025.

Dual-eligible Medicare-Medicaid beneficiaries enrolled in FFS vs MA plans.

Postacute care quality was assessed using the Centers for Medicare & Medicaid Services’ 5-star rating systems for SNFs and HH agencies. For IRFs, quality was defined by the rate of potentially preventable hospital readmissions during the IRF stay. All comparisons were risk adjusted for patient-, hospital-, and region-level factors.

In the cohort of 44 078 patients with stroke (mean [SD] age, 79.0 [8.3] years; 57.9% female), 20 497 (46.5%) were non–dual-eligible beneficiaries in FFS, 15 402 (34.9%) were non–dual-eligible beneficiaries in MA, 5256 (11.9%) were FFS dual-eligible beneficiaries, and 6190 (14.0%) were MA dual-eligible beneficiaries. Of the cohort, 17 350 (39.4%) were discharged to IRFs, 16 253 (36.9%) to SNFs, and 10 475 (23.8%) to HH care. There were no significant differences in the quality of IRFs used across groups. Compared with non–dual-eligible FFS beneficiaries, the likelihood of discharge to high-quality SNFs was lower for non–dual-eligible MA beneficiaries (odds ratio [OR], 0.82; 95% CI, 0.74-0.91), dual-eligible FFS beneficiaries (OR, 0.57; 95% CI, 0.50-0.65), and dual-eligible MA beneficiaries (OR, 0.56; 95% CI, 0.50-0.64). Similarly, non–dual-eligible MA beneficiaries were less likely to receive care from high-quality HH agencies (OR, 0.71; 95% CI, 0.62-0.82) compared with non–dual-eligible FFS beneficiaries.

In this cohort study, dual-eligible and MA-enrolled patients with stroke were less likely to receive postacute care from high-quality SNFs and HH agencies. Equitable access to high-value postacute care is essential to advancing outcomes for high-need, high-risk patients in the era of value-based care.

This cohort study compares the likelihood of discharge to high-quality postacute care settings after stroke-related acute hospitalization among dual-eligible Medicare-Medicaid beneficiaries enrolled in Medicare Advantage vs Medicare fee-for-service plans.

## Linked entities

- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Genes:** PLAT (plasminogen activator, tissue type) [NCBI Gene 5327] {aka T-PA, TPA}
- **Diseases:** pressure ulcers (MESH:D003668), infections (MESH:D007239), Ischemic Stroke (MESH:D002544), HH (OMIM:603663), PAC (MESH:C000657744), Stroke (MESH:D020521)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933277/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933277/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933277/full.md

---
Source: https://tomesphere.com/paper/PMC12933277